Grace Halsey

For your patients confined to home, whether ill or out of caution, regular virtual contact to check on status and serve as a trusted resource is important. Here are 5 tips on how to do it.

ACC.2020/WCC. The TAILOR-PCI trial found benefit to genotype-guided therapy in first 3 months post-PCI, although 1-year results fell short.

ACC.20/WCC. VICTORIA study shows patients with high-risk heart failure taking vericiguat may have lower risk of CV death, HF hospitalization.

Abbott is ramping up production of the new test that can deliver a positive COVID-19 result in 5 minutes.

Plan to attend ACC.20/WCC Virtual! The American College of Cardiology virtual 2020 scientfic sessions begin Saturday, March 28, at 8:00 am CDT. Find out how to "attend." 

Tissue-type plasminogen activator could help patients critically ill with COVID-19 avoid the need for a ventilator or get them off sooner, a new research paper concludes.

Extra precautions before and after the workday and while at home will help HCPs limit risk to family of potential exposure to COVID-19. Guidance here from the AAFP.

Nearly half of US primary care practices are not able to test for COVID-19 and do not have adequate personal protective equipment. Here is what your colleagues are saying.

The COVID-19 pandemic has made the words "isolation" and quarantine" part of daily conversation. How do you explain them to your patients?

In order to conserve clincal resources needed to care for patients with COVID-19, the American College of Cardiology suggests that a variety of procedures and visits be placed on hold.

In repsonse to the COVID-19-related surge in demand for alcohol-based hand sanitizer, the FDA has issued guidance on temporary production and compounding. 

Does COVID-19 cause lasting consequences in patients with chronic lung disease? The answer to this and other common FAQs from these patients provided by the American Lung Association.

The FDA announced that it will take no action against any party for failure to adhere to REMS during the the SARS-CoV-2 public health emergency.

There are more than 80 clinical trials in progress globally to test treatments and vaccines targeting COVID-19. We highlight 10 here.

The case fatality rate for patients with COVID-19 and CVD is higher than for cancer, chronic respiratory disease, and diabetes. Here is current guidance from the ACC.

A new study reports that coronavirus remains viable in aerosol for up to 3 hours, a finding that could help inform theories of contagion.

An investigational vaccine against coronavirus disease was administered to the first participant in the country's first clinical trial of an agent to prevent COVID-19 infection.

The American Diabetes Association warns that COVID-19 may cause severe complications in patients with diabetes. Here’s how you can help.

Fraudulent claims on treatments and cures for COVID-19 infection are flooding social media and other digital communications. Here, 6 samples of misinformation your patients may be reading.

Safety and efficacy of apixaban bested rivaroxaban in analysis of new users from a US nationwide commercial healthcare claims database.

Eliminate waiting room magazines; cross-train staff for all essential functions; reorganize waiting area to “contain” febrile patients. Check, check, check?

Research from China reported in NEJM suggests SARS-CoV-2 transmission potential of patients with minimal or no symptoms, complicating detection and containment picture.

Global leaders in obesity research plus hundreds of medical, scientific, & academic associations and institutions have taken this pledge to end the stigma.

Obesity stigma is pervasive & resilient. A landmark statement demands we eliminate the gap between the social narrative and scientific evidence.

A new orally disintegrating tablet formulation of CGRP inhibitor rimegepant may restore normal function within 1 hour in adults with migraine, according to the manufacturer.

Antihypertension drugs deliver similar reduction in CV events, a new study finds. Message: Focus on reaching target BP, not on drug class.

More than 50% of patients with obesity say weight loss is a priority for them. What percentage of their physicians feel the same? #ObesityCareWeek

Irregular sleep patterns in women may impact quality of diet and calories consumed, increasing risk for cardiometabolic disease, concludes a new study.

Liraglutide added to intensive behavior therapy in primary care practice significantly improved weight loss vs behavior therapy alone, a new study found.

Based on results from REWIND, dulaglutide is the first GLP-1 receptor agonist to be approved for both primary and secondary CV prevention in type 2 diabetes.